D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.
The heroin analogue 1-methyl-4-phenylpyridinium, MPP(+), both in vitro and in vivo, produces death of dopaminergic substantia nigral cells by inhibiting the mitochondrial NADH dehydrogenase multienzyme complex, producing a syndrome indistinguishable from Parkinson's disease. Similarly, a fragme...
Main Authors: | Kashiwaya, Y, Takeshima, T, Mori, N, Nakashima, K, Clarke, K, Veech, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Neuroregeneration Improved by Sodium-D,L-Beta-Hydroxybutyrate in Primary Neuronal Cultures
by: Csilla Ari, et al.
Published: (2024-08-01) -
The mechanisms by which the ketone body D-β-Hydroxybutyrate may improve the multiple cellular pathologies of Parkinson's disease
by: Norwitz, N, et al.
Published: (2019) -
The energetics of ion distribution: the origin of the resting electric potential of cells.
by: Veech, R, et al.
Published: (2002) -
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease
by: Kashiwaya, Y, et al.
Published: (2013) -
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease.
by: Kashiwaya, Y, et al.
Published: (2013)